Drugdiscovery >> Clinical Trials >> News
3420
Views
Cancer research UK and its phamraceutical partner gain success - drugdiscovery.com
Cancer research UK and its phamraceutical partner gain success - drugdiscovery.com


The clinical trial of Cancer research UK and its partners, such as AstraZeneca and Pfizer proved to be an outstanding success. The promising clinical trials offer a new help for lung cancer treatment.
Read More >>


Tags: lung cancer, treatment, cancer research, cancer research UK - April 24, 2014
Related Articles
3481
Views
New Clinical trial for curin B-cell Cancer New Clinical trial for curin B-cell Cancer
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1 Read More >>

Tags: B-cell, research, cancer

1636
Views
Phase III trial of Amgen's drug was an outstanding success Phase III trial of Amgen's drug was an outstanding success
Evolocumab, the new drug of Amgen has gone through Phase III. clinical trial. The result is a statistically significant reduction in low-density lipoprotein cholesterol. The new drug seems to be 66% m Read More >>

Tags: drug, competitior, cholesterol, Amgen

3980
Views
Promising success in treatment of diabetic foot ulcers Promising success in treatment of diabetic foot ulcers
Stem cell biotech company Osiris, reported a major success with its stem cell treatment of diabetic foot ulcers. The company’s stem cell therapy product-Grafix, used for wound and tissue repair, sho Read More >>

Tags: diabetic foot, diabetic foot ulcers, stem cells, successful treatment, effective treatment,

3270
Views
Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment
Eli Lilly’s investigational drug ramucirumab, missed its main goal in a late-stage study in patients with advanced breast cancer. The drug performed better in a separate study in patients with advan Read More >>

Tags: Eli Lilly, Lilly, investigational drug, clinical trials, ramucirumab, breast cancer, gastric cancer

4745
Views
Ovarian cancer drug demcizumab enters Phase 2 Ovarian cancer drug demcizumab enters Phase 2
OncoMed Pharmaceuticals’ stem cell product candidate, demcizumab (OMP-21M18) has entered Phase 1b/2 clinical trial and will be tested in combination with paclitaxel in patients with platinum-resista Read More >>

Tags: OncoMed, oncomed, demcizumab, ovarian cancer, fallopian tube cancer, primary peritoneal cancer

4225
Views
GSK has ended the trials of its new lung cancer treatment GSK has ended the trials of its new lung cancer treatment
Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer. Read More >>

Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development

3465
Views
New clinical trial in ovarian cancer New clinical trial in ovarian cancer
Adaptimmune has opened a Phase I/IIa clinical trial at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif. The patients will be treated with their own T ce Read More >>

Tags: ovarian cancer, T cells, cancer immunotherapy, TCR enhancement technology, CT antigens

4729
Views
Removing Lymph Node Helps to Cure Breast Cancer? Removing Lymph Node Helps to Cure Breast Cancer?
Less removal of lymph nodes is needed according to the new results of scientists. Formerly, when treating breast cancer, all the lymph nodes were removed in order to prevent the injured cells spread i Read More >>

Tags: cell, cancer, breast cancer

5552
Views
Sidney Kimmel Comprehensive Cancer Center sponsors Phase II. trial of MK-3475 Sidney Kimmel Comprehensive Cancer Center sponsors Phase II. trial of MK-3475
Sidney Kimmel Comprehensive Cancer Center sponsors the phase II clinical trial of a new medicine which is used for treating MSI Positive Colorectal Cancer. Read More >>

Tags: MSI Positive Colorectal Cancer, cancer, Sidney Kimmel Comprehensive Cancer Center

3216
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013